← Leaderboards
Christoph Rader
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Hematologic Neoplasms”
- Ronald T Mitsuyasu · University Of California Los Angeles$101,827,988
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Suzanne George · Brigham And Women'S Hospital$34,879,352
- Paul M. Ridker · Brigham And Women'S Hospital$34,275,148
- Norman Wolmark · Nsabp Foundation, Inc.$33,598,810
- Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr$33,598,810
Research focus
Hematologic NeoplasmsBinding (Molecular Function)Antibody -Dependent Cell CytotoxicityAntibodiesMediatingHuman Monoclonal AntibodiesT-LymphocyteMonoclonal AntibodiesLibrariesBiologicalPhage DisplayBaseChronic Lymphocytic LeukemiaInterestNeoplastic CellAllogenicHematopoietic Stem Cell TransplantationSurface AntigensDiagnosisAntibody EngineeringAutoimmune ProcessAreaGenerationsCd8b1 Gene
Grant awards (15)
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies$421,711
ZIA · FY2012 · CA · contact PI
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies$524,636
ZIA · FY2011 · CA · contact PI
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL$524,636
ZIA · FY2011 · CA · contact PI
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies$495,457
ZIA · FY2010 · CA · contact PI
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL$495,457
ZIA · FY2010 · CA · contact PI
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies$398,717
ZIA · FY2009 · CA · contact PI
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL$398,717
ZIA · FY2009 · CA · contact PI
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies$547,078
Z01 · FY2008 · CA · contact PI
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL$547,078
Z01 · FY2008 · CA · contact PI
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL$803,614
Z01 · FY2007 · CA · contact PI
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies$693,537
Z01 · FY2007 · CA · contact PI
Discovery of Drugs, Targets, and Target Strategies for I$0
Z01 · FY2006 · BC · contact PI
Antibody Engineering for Therapy and Diagnosis of Hemato$0
Z01 · FY2006 · BC · contact PI
Discovery of drugs, targets, and target strategies for i$0
Z01 · FY2005 · BC
Design, engineering, and evolution of monoclonal antibod$0
Z01 · FY2005 · BC